ISSN 0300-9092 (Print)
ISSN 2412-5679 (Online)

The role of genetic polymorphism of xenobiotic biotransformation enzymes in the development of congenital malformations in the fetus

Saltykova P.E., Shramko S.V., Savkova A.V., Gulyaeva L.F.

1) Novokuznetsk State Institute of Advanced Medical Training – Branch of the Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia, Novokuznetsk, Russia; 2) Federal Research Center of Fundamental and Translational Medicine, Novosibirsk, Russia

Over the past few decades, congenital malformations have been the leading cause of perinatal mortality, contributing significantly to infant mortality and disability. The etiology of congenital malformations is multifactorial; it is poorly understood and it requires further scientific research.
The aim of this review was to analyze data on the possible role of genetic polymorphism in the enzymes of xenobiotic biotransformation systems (CYP1A1, CYP1A2, CYP1B1, SULT1A1, GSTM, GSTT, GSTP) in the development of congenital malformations. The review included 48 publications, comprising meta-analyses, reviews and articles obtained from eLibrary, Medline, PubMed, Cochrane, and Russian State Library.
The biotransformation of xenobiotics is genetically determined and serves to detoxify and eliminate toxic exogenous and endogenous substances from the body. The activity of the xenobiotic biotransformation enzyme system is controlled by cytochrome P450 genes. Numerous studies have found a connection between the genetic polymorphism of xenobiotic biotransformation enzyme system and the occurrence of various diseases, as well as reproductive dysfunction and miscarriage in women living in areas with poor environmental conditions. In the last decade, a series of studies has been devoted to the search for a link between the risk of congenital heart defects in the fetus and the presence of genetic polymorphisms CYP1A1, CYP1A2, CYP1B1 and CYP2E in mothers living in environments with high levels of pollution and stress. 
Conclusion. Polymorphisms in genes encoding enzymes involved in xenobiotic biotransformation systems have a definite influence on the risk of developing congenital malformations. It is advisable to investigate the relationship between of allelic variants of genes responsible for modulating the toxic effects of xenobiotics on the developing fetus, especially in regions with high anthropogenic pressure.

Authors’ contributions. Saltykova P.E., Shramko S.V. – developing the concept and design of the study, writing the text; Saltykova P.E., Savkova A.V. – collecting and processing the material; Shramko S.V., Gulyaeva L.F. – editing the article, final approval of the article for publication.
Conflicts of interest. The authors declare no potential conflicts of interest.
Funding. The study was carried out within the framework of the budget project of the Federal Research Center for Physical and Mathematical Sciences on the topic ‘Postgenomic high-tech studies of the mechanisms of development of socially significant diseases and stress-induced conditions’.
For citation: Saltykova P.E., Shramko S.V., Savkova A.V., Gulyaeva L.F. The role of genetic polymorphism of 
xenobiotic biotransformation enzymes in the development of congenital malformations in the fetus.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2026; (5): 5-11 (in Russian)
https://dx.doi.org/10.18565/aig.2025.367

Keywords

enzymes of xenobiotic biotransformation system
congenital malformations in the fetus
CYP1A1
CYP1A2
CYP1B1
SULT1A1
GSTM
GSTT
GSTP

References

  1. Воеводин С.М., Шеманаева Т.В. Профилактика врожденных пороков развития у плода (обзор литературы). Современные проблемы здравоохранения и медицинской статистики. 2018; 2: 86-93. [Voevodin S.M., Shemanaeva T.V. Prevention of congenital malformations in the fetus (literature review). Modern problems of health care and medical statistics. 2018; 2: 86-93 (in Russian)].
  2. Всемирная организация здравоохранения. Врожденные заболевания. Доступно по: https://www.who.int/ru/news-room/fact-sheets/detail/birth-defects. [World Health Organization. Congenital diseases. Available at: https://www.who.int/ru/news-room/fact-sheets/detail/birth-defects ]
  3. Пак В.С., Люшнина Д.Г., Набережнев Ю.И., Бокерия Е.Л., Зарецкая Н.В., Большакова А.С., Барков И.Ю., Тетруашвили Н.К., Трофимов Д.Ю. Частота хромосомной патологии при пороках сердца плода, врожденной диафрагмальной грыже и неиммунной водянке плода по данным молекулярного кариотипирования (опыт Национального Центра). Акушерство и гинекология. 2024; 12: 33-41. [Pak V.S., Lyushnina D.G., Naberezhnev Yu.I., Bokerija E.L., Zaretskaya N.V., Bolshakova A.S., Barkov I.Yu., Tetruashvili N.K., Trofimov D.Yu. Prevalence of chromosomal abnormalities in fetal heart defects, congenital diaphragmatic hernia and non-immune hydrops fetalis based on molecular karyotyping data (experience of the National Center). Obstetrics and Gynecology. 2024; (12): 33-41 (in Russian)]. https://dx.doi.org/10.18565/aig.2024.2811
  4. Liu Y., Chen S., Zühlke L., Black G.C., Choy M.K., Li N. et al. Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies. Int. J. Epidemiol. 2019; 48(2): 455-63. https://dx.doi.org/10.1093/ije/dyz009
  5. Демикова Н.С., Подольная М.А., Лапина А.С. Анализ эпидемиологической картины врожденных пороков развития в регионах Российской Федерации. Медицинская генетика. 2020; 19(7): 31-2. [Demikova N.S., Podol'naya M.A., Lapina A.S. Analysis of the epidemiological picture of congenital defects in the regions of the Russian Federation. Medical genetics. 2020; 19(7): 31-2 (in Russian)]. https://dx.doi.org/10.25557/2073-7998.2020.07.31-32
  6. Федеральная служба государственной статистики. Здравоохранение в России 2021. Статистический сборник. Доступно по: https://rosstat.gov.ru/folder/210/document/13218 [Federal State Statistics Service. Healthcare in Russia 2021. Statistical collection. Available at: https://rosstat.gov.ru/folder/210/document/13218 (in Russian)].
  7. Заяева Е.Е., Андреева Е.Н., Демикова Н.С. Эпидемиологическая характеристика врожденных пороков развития: данные регистра Московской области. Российский вестник перинатологии и педиатрии. 2022; 67(3): 39-46. [Zayaeva E.E., Andreeva E.N., Demikova N.S. Epidemiological characteristics of congenital malformations: data from the Moscow Region register. Russian Bulletin of Perinatology and Pediatrics. 2022; 67(3): 39-46 (in Russian)]. https://dx.doi.org/10.21508/1027-4065-2022-67-3-39-46
  8. Karas Kuželički N., Šmid A., Vidmar Golja M., Kek T., Eberlinc A., Geršak B. et al. Higher incidence of common polymorphisms in the genes of folate and methionine cycles in children with orofacial clefs and congenital heart defects compared to their unaffected siblings. Birth Defects Res. 2024; 116(11): e2408. https://dx.doi.org/10.1002/bdr2.2408
  9. Karas Kuželički N., Doljak B. Congenital heart disease and genetic changes in folate/methionine cycles. Genes (Basel). 2024; 15(7): 872. https://dx.doi.org/10.3390/genes15070872
  10. Постригань А.Е., Жалсанова И.Ж., Фонова Е.А., Скрябин Н.А. Гены-модификаторы как причина клинического полиморфизма болезни Вильсона-Коновалова. Генетика. 2021; 57(5): 516-27. [Postrigan A.E., Zhalsanova I.Zh., Fonova E.A., Skryabin N.A. Modifier genes as a cause of clinical polymorphism in Wilson-Konovalov patient. Genetics. 2021; 57(5): 516-27 (in Russian)]. https://dx.doi.org/10.31857/S001667582105009X
  11. Мирзарахимова К.Р. Влияние факторов окружающей среды на формирование врожденных пороков развития у детей. Medicus. 2020; 6(36): 48-54. [Mirzarakhimova K.R. The influence of environmental factors on the formation of congenital malformations in children. Medicus. 2020; 6(36): 48-54 (in Russian)]
  12. Коськина Е.В., Глебова Л.А., Бачина А.В., Чухров Ю.С., Власова О.П., Пеганова Ю.А. Гигиеническая оценка формирования нарушения здоровья детского населения при комплексном воздействии факторов окружающей среды в углехимических центрах Кузбасса. Фундаментальная и клиническая медицина. 2016; 1(1): 57-63. [Koskina E.V., Glebova L.A., Bachina A.V., Chukhrov Yu.S., Vlasova O.P., Peganova Yu.A. Hygienic assessment of the formation of health problems in the child population under the complex influence of environmental factors in the coal chemical centers of Kuzbass. Fundamental and Clinical Medicine. 2016; 1(1): 57-63 (in Russian)].
  13. Салтыкова П.Е., Шрамко С.В., Чубарь Е.А., Власенко А.Е. Частота и структура врожденных пороков развития в городе Новокузнецке за период 2012-2021 гг. Мать и дитя в Кузбассе, 2024; 1(96): 32-9. [Saltykova P.E., Shramko S.V., Chubar E.A., Vlasenko A.E. Frequency and structure of congenital malformations in the city of Novokuznetsk for the period 2012-2021. Mother and Child in Kuzbass. 2024; 1(96): 32-9 (in Russian)]. https://dx.doi.org/10.24412/2686-7338-2024-1-32-39
  14. Zhao L., Chen L., Yang T., Wang L., Wang T., Zhang S. et al. Parental smoking and the risk of congenital heart defects in offspring: an updated meta-analysis of observational studies. Eur. J. Prev. Cardiol. 2020; 27(12): 1284-93. https://dx.doi.org/10.1177/2047487319831367
  15. Бачина А.В., Коськина Е.В., Глебова Л.А., Чухров Ю.С., Попкова Л.В., Пеганова Ю.А. Гигиеническое обоснование региональной модели мониторинга врожденной патологии в Кузбассе. Медицина в Кузбассе. 2017; 16(1): 30-9. [Bachina A.V., Koskina E.V., Glebova L.A., Chukhrov Yu.S., Popkova L.V., Peganova Yu.A. Hygienic justification for a regional model for monitoring congenital pathology in Kuzbass. Medicine in Kuzbass. 2017; 16(1): 30-9 (in Russian)].
  16. Шрамко С.В., Матошин С.В., Гуляева О.Н., Самусь И.В. Ассоциация полиморфизма генов системы биотрансформации ксенобиотиков с ранней потерей первой беременности в крупном промышленном регионе. Акушерство и гинекология. 2024; 8: 58-68. [Shramko S.V., Matoshin S.V., Gulyaeva O.N., Samus I.V. Association of gene polymorphism of the xenobiotic biotransformation system with early loss of the first pregnancy in a large industrial region. Obstetrics and Gynecology. 2024; (8): 58-68 (in Russian)]. https://dx.doi.org/10.18565/aig.2024.91
  17. Криничная Н.В., Плохотниченко А.В. Врожденная и наследственная патологии: современное состояние проблемы в Российской Федерации. В кн.: Гаврик С.Ю., ред. Естественные науки: фундаментальные и прикладные вопросы. Сборник материалов Всероссийской научно-практической конференции (12 февраля 2025 г.). Луганск; 2025: 78-91 [Krinichnaya N.V., Plokhotnichenko A.V. Congenital and hereditary pathologies: the current state of the problem in the Russian Federation. In: Gavrik S.Yu., ed. Natural sciences: fundamental and applied issues. Collection of materials of the All-Russian scientific and practical conference (February 12, 2025). Lugansk; 2025: 78-91 (in Russian)].
  18. Moreira S., Inocêncio L.C., Jorge B.C., Reis AC.C., Hisano H., Arena A.C. Effects of benzo(a)pyrene at environmentally relevant doses on embryo-fetal development in rats. Environ. Toxicol. 2021; 36(5): 831-9. https://dx.doi.org/10.1002/tox.23085
  19. Шуматова Т.А., Коваленко Д.В. Роль генов второй фазы детоксикации ксенобиотиков в патогенезе мультифакториальных заболеваний. Тихоокеанский медицинский журнал. 2021; 4: 16-20. [Shumatova T.A., Kovalenko D.V. The role of genes of the second phase of detoxification of xenobiotics in the pathogenesis of multifactorial diseases. Pacific Medical Journal. 2021; 4: 16-20 (in Russian)]. https://dx.doi.org/10.34215/1609-1175-2021-4-16-20
  20. Костюк С.А. Диагностическое и прогностическое значение молекулярно-биологических маркеров онкогенеза и эффективности противоопухолевой терапии. Медицинские новости. 2016; 7: 2-7. [Kostyuk S.A. Diagnostic and prognostic value of molecular biological markers of tumorogenesis and efficiency of anti-tumor therapy. Medical News. 2016; 7: 2-7 (in Russian)].
  21. Очилов А.К., Мусаева Д.М. Особенности гена CYP2C19 для индивидуализиции фармакотерапии. Новый день в медицине. 2020; 1(29): 65-8. [Ochilov A.K., Musaeva D.M. Features of the CYP2C19 gene for individualization of pharmacotherapy. A new day in medicine. 2020; 1(29): 65-8 (in Russian)].
  22. Singh N., Rashid S., Rashid S., Sati H.C., Gupta S., Vaswani M. et al. Genetic polymorphisms in phase II metabolizing enzymes in alcoholic and idiopathic chronic pancreatitis: Indian scenario. Indian J. Gastroenterol. 2023; 42(2): 199-208. https://dx.doi.org/10.1007/s12664-022-01320-w
  23. Костюк С.А. Система биотранформации ксенобиотиков: гены детоксикации. Медицинские новости. 2020; 11(314): 12-6. [Kostyuk S.A. Xenobiotic biotransformation system: detoxification genes. Medical News. 2020; 11(314): 12-6 (in Russian)].
  24. Li M., Li A., He R., Dang W., Liu X., Yang T. et al. Gene polymorphism of cytochrome P450 significantly affects lung cancer susceptibility. Cancer Med. 2019; 8(10): 4892-905. https://dx.doi.org/10.1002/cam4.2367
  25. Hidaka A., Sasazuki S., Matsuo K., Ito H., Charvat H., Sawada N. et al. CYP1A1, GSTM1 and GSTT1 genetic polymorphisms and gastric cancer risk among Japanese: A nested case-control study within a large-scale population-based prospective study. Int. J. Cancer. 2016; 139(4): 759-68. https://dx.doi.org/10.1002/ijc.30130
  26. Mohammadi H., Momeni Roochi M., Rezaei F., Garajei A., Heidar H., Ghaderi B. et al. Association between the CYP1A1 MspI polymorphism and risk of head and neck cancer: a meta-analysis. Sci. Rep. 2022; 12(1): 1527. https://dx.doi.org/10.1038/s41598-022-05274-z
  27. Kourie H.R., Zouein J., Succar B., Mardirossian A., Ahmadieh N., Chouery E. et al. Genetic polymorphisms involved in bladder cancer: a global review. Oncol. Rev. 2023; 17: 10603. https://dx.doi.org/10.3389/or.2023.10603
  28. Elfaki I., Mir R., Almutairi F.M., Duhier F.M. Cytochrome P450: polymorphisms and roles in cancer, diabetes and atherosclerosis. Asian Pac. J. Cancer Prev. 2018; 19(8): 2057-70. https://dx.doi.org/10.22034/APJCP.2018.19.8.2057
  29. Sen A., Stark H. Role of cytochrome P450 polymorphisms and functions in development of ulcerative colitis. World J. Gastroenterol. 2019; 25(23): 2846-62. https://dx.doi.org/10.3748/wjg.v25.i23.2846
  30. Da Silva I.M., Maraslis F.T., Kawasaki J.AI., Aida N.K., Barcelos GR.M., Koike A. et al. Allelic variants in xenobiotic metabolism genes predict susceptibility and worse prognosis of urothelial bladder cancer. Pathol. Res. Pract. 2025; 266: 155767. https://dx.doi.org/10.1016/j.prp.2024.155767
  31. Амромина А.М., Ситников И.А., Шаихова Д.Р. Взаимосвязь полиморф­ных вариантов генов GSTM1, GSTT1, GSTP1 с риском развития заболеваний (обзор литературы). Гигиена и санитария. 2021; 100(12): 1385-90. [Amromina A.M., Sitnikov I.A., Shaikhova D.R. The relationship of polymorphic variants of the GSTM1, GSTT1, GSTP1 genes with the risk of developing diseases (literature review). Hygiene and Sanitation. 2021; 100(12): 1385-90 (in Russian)]. https://dx.doi.org/10.47470/0016-9900-2021-100-12-1385-1390
  32. Sobha S.P., Sankar J., Muthusamy K., Kesavarao K.E. Risk of cardiovascular complications among type 2 diabetes mellitus patients with GSTP1 genetic polymorphism: a nested case-control study and docking studies. Biochem. Genet. 2025; 63(3): 2438-54. https://dx.doi.org/10.1007/s10528-024-10823-4
  33. Лызикова Ю.А. Полиморфизм генов PGR, ERΑ, CYP1A1, CYP1A2 у пациенток с гиперпластическими процессами эндометрия, проживающих на территории Гомельской области. Репродуктивное здоровье. Восточная Европа. 2024; 14(5): 577-83. [Lyzikova Yu.A. Polymorphism of the PGR, ERΑ, CYP1A1, CYP1A2 genes in patients with endometrial hyperplastic processes living in the Gomel region. Reproductive health. Eastern Europe. 2024; 14(5): 577-83 (in Russian)]. https://dx.doi.org/10.34883/PI.2024.14.5.002
  34. Данилова Л.Н., Червова В.О., Артымук Н.В. Полиморфизм генов CYP1A1, CYP1A2, CYP19, SULT1A1 у инфертильных женщин с наружным генитальным эндометриозом. Фундаментальная и клиническая медицина. 2018; 3(3): 25-34. [Danilova L.N., Chervova V.O., Arty'muk N. V. Polymorphism of the CYP1A1, CYP1A2, CYP19, and SULT1A1 genes in infertile women with external genital endometriosis. Fundamental and Clinical Medicine. 2018; 3(3): 25-34 (in Russian)]. https://dx.doi.org/10.23946/2500-0764-2018-3-3-25-34
  35. Шуматова Т.А., Коваленко Д.В. Роль генов второй фазы детоксикации ксенобиотиков в патогенезе мультифакторных заболеваний. Тихоокеанский медицинский журнал. 2021; 4(86): 16-20. [Shumatova T.A., Kovalenko D.V. The role of genes of the second phase of xenobiotic detoxification in the pathogenesis of multifactorial diseases. Pacific Medical Journal. 2021; 4(86): 16-20 (in Russian)]. https://dx.doi.org/10.34215/1609-1175-2021-4-16-20
  36. Li S., Li G., Kong F., Liu Z., Li N., Li Y. et al. The association of CYP1A1 gene with cervical cancer and additional SNP-SNP interaction in chinese women. J. Clin. Lab. Anal. 2016; 30(6): 1220-25. https://dx.doi.org/10.1002/jcla.22006
  37. Гордеева Л.А., Попова О.С., Воронина Е.Н., Шаталина И.В., Оленникова Р.В., Нерсесян С.Л., Филипенко М.Л., Глушков А.Н. Ассоциации полиморфизма генов ферментов биотрансформации ксенобиотиков с невынашиванием беременности в ранние сроки. Молекулярная медицина. 2017; 15(3): 37-44. [Gordeeva L.A., Popova O.S., Voronina E.N., Shatalina I.V., Olennikova R.V., Nersesyan S.L., Filipenko M.L., Glushkov A.N. Assotiation of genes polymorphisms of xenobiotics-metabolizing enzymes with recurrent miscarriage. Molecular medicine. 2017; 15(3): 37-44 (in Russian)].
  38. Носкова И.Н., Артымук Н.В., Гуляева Л.Ф. Полиморфизм генов CYP1A1, CYP1A2, CYP19 и SULT1A1 у женщин с невынашиванием беременности в ранние сроки. Фундаментальная и клиническая медицина. 2019; 4(4): 47-57. [Noskova I.N., Artymuk N.V., Gulyaeva L.F. Polymorphism of the CYP1A1, CYP1A2, CYP19 and SULT1A1 genes in women with early pregnancy loss. Fundamental and Clinical Medicine. 2019; 4(4): 47-57 (in Russian)]. https://dx.doi.org/10.23946/2500-0764-2019-4-4-47-57
  39. Li N., Mu Y., Liu Z., Deng Y., Guo Y., Zhang X. et al. Assessment of interaction between maternal polycyclic aromatic hydrocarbons exposure and genetic polymorphisms on the risk of congenital heart diseases. Sci. Rep. 2018; 8(1): 3075. https://dx.doi.org/10.1038/s41598-018-21380-3
  40. Diao J., Zhao L., Luo L., Li J., Li Y., Zhang S. et al. Associations and interaction effects of maternal smoking and genetic polymorphisms of cytochrome P450 genes with risk of congenital heart disease in offspring: a case-control study. Medicine (Baltimore). 2021; 100(23): 226-68. https://dx.doi.org/10.1097/MD.0000000000026268
  41. Qin J.B., Luo L., Sun M.T., Huang P., Wang T.T., Zhang S.M. et al. Association between maternal drug use and cytochrome P450 genetic polymorphisms and the risk of congenital heart defects in offspring. Biomed. Environ. Sci. 2022; 35(1): 45-57. https://dx.doi.org/10.3967/bes2022.006
  42. Гуляева О.Н., Жукова А.Г., Казицкая А.С., Лузина Ф.А., Алексеева М.В., Ренге Л.В., Рябов В.А. Степень антропогенной нагрузки, полиморфизм генов системы биотрансформации ксенобиотиков и врожденные пороки развития плода как звенья одной цепи. Гигиена и санитария. 2021; 100(7): 658-62. [Gulyaeva O.N., Zhukova A.G., Kazitskaya A.S., Luzina F.A., Alekseeva M.V., Renge L.V., Ryabov V.A. The degree of anthropogenic load, polymorphism of genes of the xenobiotic biotransformation system and congenital malformations of the fetus as links in one chain. Hygiene and Sanitation. 2021; 100(7): 658-62 (in Russian)]. https://dx.doi.org/10.47470/0016-9900-2021-100-7-658-662
  43. Xu H. Bisphenol A affects estradiol metabolism by targeting CYP1A1 and CYP19A1 in human placental JEG-3 cells. Toxicol. In Vitro. 2019; 61: 104615. https://dx.doi.org/10.1016/j.tiv.2019.104615
  44. Barbosa A.C.S., Feng Y., Yu C., Huang M., Xie W. Estrogen sulfotransferase in the metabolism of estrogenic drugs and in the pathogenesis of diseases. Expert Opin. Drug Metab. Toxicol. 2019; 15(4): 329-39. https://dx.doi.org/10.1080/17425255.2019.1588884
  45. Гордеева Л.А., Поленок Е.Г., Воронина Е.Н., Соколова Е.А., Мун С.А., Чернокульская К.С., Култаева И.В., Оскорбина О.С., Глушков А.Н. Изучение связи между иммунным ответом на ксено- и эндобиотики и полиморфными локусами генов ферментов биотрансформации у женщин с врожденными пороками развития у плода. Клиническая лабораторная диагностика. 2023; 68(9): 559-69. [Gordeeva L.A., Polenok E.G., Voronina E.N., Sokolova E.A., Mun S.A., Chernokulskaya K.S., Kultaeva I.V., Oskorbina O.S., Glushkov A.N. The research of relationship between immune response to xeno- and endobiotics and polymorphic loci of gene biotransformation enzymes in women with congenital malformations of fetus. Russian Clinical Laboratory Diagnostics. 2023; 68(9): 559-69 (in Russian)]. https://dx.doi.org/10.51620/0869-2084-2023-68-9-559-569

Received 10.12.2025

Accepted 31.03.2026

About the Authors

Polina E. Saltykova, Teaching Assistant at the Department of Obstetrics and Gynecology, Novokuznetsk State Institute of Advanced Medical Training – branch of RMACPE, Ministry of Health of Russia, 654005, Russia, Kemerovo region, Novokuznetsk, Stroiteley Ave., 5, +7(913)433-20-64, urtika66@gmail.com,
https://orcid.org/0000-0003-2591-6798
Svetlana V. Shramko, Dr. Med. Sci., Associate Professor, Professor at the Department of Obstetrics and Gynecology, Novokuznetsk State Institute for Advanced Medical Training – branch of RMACPE, Ministry of Health of Russia, 654005, Russia, Kemerovo region, Novokuznetsk, Stroiteley Ave., 5, +7(961)714-00-13, shramko_08@mail.ru, https://orcid.org/0000-0003-1299-165Х
Alina V. Savkova, Junior Researcher at the Laboratory of Molecular Mechanisms of Carcinogenesis, Federal Research Center of Fundamental and Translational Medicine, 630117, Russia, Novosibirsk region, Novosibirsk, Timakova str., 2/12; Senior Lecturer, IESEN NSPU, +7(905)933-32-19, bifshteks@inbox.ru,
https://orcid.org/0000-0001-8930-4622
Lyudmila F. Gulyaeva, Dr. Bio. Sci., Professor, Head of the Laboratory of Molecular Mechanisms of Carcinogenesis, Federal Research Center of Fundamental and Translational Medicine, 630117, Russia, Novosibirsk region, Novosibirsk, Timakova str., 2/12, +7(384)334-88-40, lfguliaeva@frcftm.ru, https://orcid.org/0000-0002-7693-377
Corresponding author: Polina E. Saltykova, urtika66@gmail.com

Similar Articles